Valuation: Abbott Laboratories

Market Cap 155B 136B 125B 115B 218B 14,962B 222B 1,497B 587B 7,313B 584B 571B 25,206B P/E 2026 *
22.3x
P/E 2027 * 19.1x
Enterprise Value 167B 146B 135B 124B 235B 16,086B 239B 1,610B 632B 7,863B 628B 614B 27,100B EV / Sales 2026 *
3.33x
EV / Sales 2027 * 3x
Free-Float
86.73%
Yield 2026 *
2.85%
Yield 2027 * 3.04%
1 day+0.15%
1 week-6.86%
Current month-1.62%
1 month+1.24%
3 months-11.66%
6 months-28.58%
Current year-28.75%
1 week 87.64
Extreme 87.64
94.98
1 month 87.21
Extreme 87.21
98.14
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Date Insider Type Main position Quantity % Market Cap.
06-30Free

Director

363 0.0000%
06-30Tax

EXECUTIVE VICE PRESIDENT

-269 0.0000%
06-30Free

Director

432 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.06%-6.86%-32.39%-17.29% 155B
+1.48%-4.01%-10.32%-8.19% 102B
-1.89%-2.60%-0.16%+54.93% 58.81B
-0.99%+4.73%+38.04%+53.57% 52.82B
+2.81%-0.91%-12.54%-40.29% 41.51B
+2.02%-8.30% - - 32.69B
-1.88%-1.14%-14.77%-47.04% 28.6B
+0.38%+0.82%+59.92%-6.78% 25.27B
+1.31%-1.82%-6.35%-7.69% 20.34B
+0.27%+5.41%-3.65%-17.97% 20.99B
Average +0.35%-2.41%+1.98%-4.08% 53.75B
Weighted average by Cap. +0.32%-3.95%-7.33%-2.32%

Financials

2026 *2027 *
Net sales 50.26B 43.94B 40.54B 37.26B 70.6B 4,836B 71.81B 484B 190B 2,364B 189B 185B 8,147B 54.74B 47.86B 44.15B 40.58B 76.9B 5,267B 78.21B 527B 207B 2,574B 206B 201B 8,873B
Net income 6.92B 6.05B 5.58B 5.13B 9.73B 666B 9.89B 66.66B 26.16B 326B 26B 25.43B 1,122B 8.28B 7.24B 6.68B 6.14B 11.64B 797B 11.84B 79.77B 31.3B 390B 31.11B 30.43B 1,343B
Net Debt 11.69B 10.22B 9.43B 8.67B 16.42B 1,125B 16.7B 113B 44.16B 550B 43.9B 42.94B 1,895B 8.84B 7.73B 7.13B 6.55B 12.42B 851B 12.63B 85.12B 33.4B 416B 33.2B 32.47B 1,433B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
15/07/26 $89.27 +0.35% 16,293,733
14/07/26 $88.96 -3.42% 12,473,875
13/07/26 $92.11 -1.94% 11,756,235
10/07/26 $93.93 -0.50% 6,913,069
09/07/26 $94.40 -0.82% 8,357,750
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
89.27USD
Average target price
116.40USD
Spread / Average Target
+30.39%

Quarterly revenue - Rate of surprise